| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation elongation factor activity | 2.42e-05 | 20 | 174 | 4 | GO:0003746 | |
| Domain | Spectrin | 5.61e-05 | 23 | 174 | 4 | PF00435 | |
| Domain | ACTININ_2 | 5.61e-05 | 23 | 174 | 4 | PS00020 | |
| Domain | ACTININ_1 | 5.61e-05 | 23 | 174 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.61e-05 | 23 | 174 | 4 | IPR001589 | |
| Domain | G_TR_CS | 6.41e-05 | 9 | 174 | 3 | IPR031157 | |
| Domain | Transl_elong_EF1A_euk/arc | 8.63e-05 | 2 | 174 | 2 | IPR004539 | |
| Domain | Spectrin_repeat | 1.44e-04 | 29 | 174 | 4 | IPR002017 | |
| Domain | G_TR_1 | 2.12e-04 | 13 | 174 | 3 | PS00301 | |
| Domain | SPEC | 2.13e-04 | 32 | 174 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.13e-04 | 32 | 174 | 4 | IPR018159 | |
| Domain | - | LRRC3C NLRP7 RTN4R LRRTM3 LRRC43 FBXL16 PXDN CEP78 LRRC56 FLRT3 LRRC15 | 2.18e-04 | 321 | 174 | 11 | 3.80.10.10 |
| Domain | Leu-rich_rpt | LRRC3C RTN4R LRRTM3 LRRC43 FBXL16 PXDN CEP78 LRRC56 FLRT3 LRRC15 | 2.35e-04 | 271 | 174 | 10 | IPR001611 |
| Domain | L_dom-like | LRRC3C NLRP7 RTN4R LRRTM3 LRRC43 FBXL16 PXDN CEP78 LRRC56 FLRT3 LRRC15 | 2.62e-04 | 328 | 174 | 11 | IPR032675 |
| Domain | LRRNT | 3.11e-04 | 98 | 174 | 6 | IPR000372 | |
| Domain | LRRNT | 3.11e-04 | 98 | 174 | 6 | SM00013 | |
| Domain | PKS_ER | 4.07e-04 | 16 | 174 | 3 | IPR020843 | |
| Domain | PKS_ER | 4.07e-04 | 16 | 174 | 3 | SM00829 | |
| Domain | EFTu-like_2 | 5.85e-04 | 18 | 174 | 3 | IPR004161 | |
| Domain | GTP_EFTU_D2 | 5.85e-04 | 18 | 174 | 3 | PF03144 | |
| Domain | G_TR_2 | 5.85e-04 | 18 | 174 | 3 | PS51722 | |
| Domain | LRR | 6.04e-04 | 201 | 174 | 8 | PS51450 | |
| Domain | TF_GTP-bd_dom | 6.90e-04 | 19 | 174 | 3 | IPR000795 | |
| Domain | ADH_zinc_N | 6.90e-04 | 19 | 174 | 3 | PF00107 | |
| Domain | ADH_C | 6.90e-04 | 19 | 174 | 3 | IPR013149 | |
| Domain | fn3 | 8.20e-04 | 162 | 174 | 7 | PF00041 | |
| Domain | LRR_8 | 1.12e-03 | 171 | 174 | 7 | PF13855 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.26e-03 | 6 | 174 | 2 | PS51460 | |
| Domain | Rudment_hybrid_motif | 1.26e-03 | 6 | 174 | 2 | IPR011054 | |
| Domain | GAS2 | 1.26e-03 | 6 | 174 | 2 | PF02187 | |
| Domain | - | 1.26e-03 | 6 | 174 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.26e-03 | 6 | 174 | 2 | IPR003108 | |
| Domain | GAS2 | 1.26e-03 | 6 | 174 | 2 | SM00243 | |
| Pubmed | RANBP10 ANKFY1 WDR7 SYNE1 GRIA4 SIPA1 GRM3 EEF1A1 EEF1A2 CCDC88C PALS1 CNTNAP5 IGF2R DST CSNK1A1 PEX5 MACF1 RIMBP2 CEP131 PARD3 NIPBL GOLGA2 LRRC15 CNTN1 ANKS1A | 3.03e-11 | 963 | 178 | 25 | 28671696 | |
| Pubmed | ACACB WDR7 RNF213 APOB TRIP12 ADCY9 KIF20A CASP12 IGF2BP1 IGF2BP3 IGF2R DST IFFO2 PEX5 RAI14 CEP131 LRBA PARD3 PTGES3 SEC23B | 3.83e-09 | 777 | 178 | 20 | 35844135 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX47 MYH11 SYNE1 ACO2 GART NOB1 WDR46 SMC4 APOB EEF1A1 EEF1A1P5 IGF2BP1 FASN IGF2BP3 DST PXDN CSNK1A1 RRP12 RAI14 RIOK2 KIF22 | 2.10e-08 | 949 | 178 | 21 | 36574265 |
| Pubmed | KNTC1 MYH11 NUP85 ACACB NLRP7 PCDHGA9 SYNE1 ACO2 ZSCAN26 SMC4 GRIA4 APOB LRRC43 TRIP12 EEF1A1 EEF1A2 RGS14 NEK2 FASN DST PXDN KRT71 MACF1 CEP295 ZNF350 NIPBL | 2.52e-08 | 1442 | 178 | 26 | 35575683 | |
| Pubmed | 2.55e-08 | 130 | 178 | 9 | 12421765 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX47 ANK1 NUP85 ACACB ACO2 GART NOB1 WDR46 SMC4 GCDH IDH2 TRIP12 EEF1A1 EEF1A2 IGF2BP1 FASN IGF2BP3 RRP12 LRBA RIOK2 PTGES3 NIPBL SEC23B KIF22 | 7.66e-08 | 1318 | 178 | 24 | 30463901 |
| Pubmed | NUP85 GART NOB1 SMC4 GCDH COPS2 EEF1A1 ITFG1 TFR2 IVNS1ABP IGF2BP1 FASN IGF2BP3 IGF2R PXDN SORL1 | 1.25e-07 | 613 | 178 | 16 | 22268729 | |
| Pubmed | 1.33e-07 | 76 | 178 | 7 | 27542412 | ||
| Pubmed | MYH11 WDR7 SYNE1 ACO2 SPTB IDH2 SIPA1 GRM3 EEF1A1 EEF1A2 MLXIPL FASN FBXL16 DST NRXN2 CSNK1A1 MACF1 RIMBP2 RAI14 UQCRC1 PTGES3 PBXIP1 CNTN2 CNTN1 | 3.42e-07 | 1431 | 178 | 24 | 37142655 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX47 NUP85 SYNE1 GART WDR46 SMC4 TRRAP TRIP12 EEF1A1 IGF2BP1 FASN IGF2BP3 IGF2R DST RRP12 PEX5 MACF1 CEP131 NIPBL KIF22 | 3.43e-07 | 1024 | 178 | 20 | 24711643 |
| Pubmed | ACACB SYNE1 TRIP12 IGF2BP1 IGF2BP3 DST MACF1 RAI14 LRBA ANXA9 | 3.98e-07 | 234 | 178 | 10 | 36243803 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PANK3 ALPK1 TRIP12 EEF1A1 EEF1A2 IVNS1ABP CCDC88C MLXIPL DST DCP1B CSNK1A1 SRGAP1 MACF1 RAI14 CEP131 PARD3 SEC23B ANKS1A | 5.21e-07 | 861 | 178 | 18 | 36931259 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX47 WDR7 SYNE1 ACO2 HMGXB4 IDH2 TRRAP TRIP12 EEF1A1 IGF2BP1 IGF2BP3 INTS5 DST NRXN2 RRP12 MACF1 NIPBL PBXIP1 SEC23B CBX8 | 8.07e-07 | 1082 | 178 | 20 | 38697112 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 ANKFY1 PLEKHG4 ACO2 SNX17 GART NOB1 WDR46 SMC4 TRRAP TRIP12 NT5DC1 KIF20A FASN DST RRP12 MACF1 RAI14 UQCRC1 PARD3 RIOK2 NIPBL | 1.83e-06 | 1353 | 178 | 22 | 29467282 |
| Pubmed | NUP85 WDR7 SYNE1 GART SMC4 APOB TRRAP NUDT13 EEF1A1 IVNS1ABP CASP12 FASN IGF2BP3 CSNK1A1 GOLGA2 ANKS1A | 1.90e-06 | 754 | 178 | 16 | 35906200 | |
| Pubmed | A physical interaction network of dengue virus and human proteins. | 1.92e-06 | 18 | 178 | 4 | 21911577 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DDX47 ANK1 ACACB RBM26 SMC4 COPS2 TRRAP TRIP12 RRP12 WNT10A RAI14 LRBA GOLGA2 | 1.93e-06 | 497 | 178 | 13 | 36774506 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KNTC1 NUP85 IFT20 SYNE1 COPS2 POF1B YARS2 KIF20A NEK2 IGF2BP1 FASN IGF2BP3 CEP78 CSNK1A1 RRP12 IFFO2 RAI14 CEP131 NIPBL GOLGA2 | 2.18e-06 | 1155 | 178 | 20 | 20360068 |
| Pubmed | KDM3A SYNE1 SPTB TRIP12 SH2B1 EEF1A1 EEF1A2 SETDB1 FBXL16 DST LRP4 MACF1 DAAM2 SYT4 RAI14 ZNF350 UQCRC1 LRBA PTGES3 NIPBL PBXIP1 | 2.95e-06 | 1285 | 178 | 21 | 35914814 | |
| Pubmed | 3.01e-06 | 20 | 178 | 4 | 21689717 | ||
| Pubmed | GART SMC4 GCDH APOB TRRAP TRIP12 IVNS1ABP FASN IGF2BP3 IGF2R DST PXDN MACF1 RAI14 UQCRC1 TOR3A RIOK2 NIPBL SEC23B KIF22 CDK7 | 3.41e-06 | 1297 | 178 | 21 | 33545068 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX47 KNTC1 ANKFY1 SYNE1 ACO2 GART WDR46 RBM26 SMC4 APOB IDH2 EEF1A1 YARS2 IVNS1ABP IGF2BP1 FASN IGF2R RRP12 UQCRC1 GFM1 PTGES3 NIPBL | 4.20e-06 | 1425 | 178 | 22 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 SPNS2 SYNE1 ACO2 GART IDH2 EEF1A1 EEF1A2 FASN DST CSNK1A1 MACF1 DAAM2 UQCRC1 LRBA PTGES3 | 4.51e-06 | 807 | 178 | 16 | 30575818 |
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 37953328 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | WDR7 SYNE1 NOB1 TRRAP ITFG1 PALS1 IGF2R PEX5 LRP4 MACF1 RAI14 FLRT3 LRBA PARD3 EPHA7 | 4.95e-06 | 719 | 178 | 15 | 35337019 |
| Pubmed | GART WDR46 SMC4 TRRAP TRIP12 FASN IGF2BP3 IGF2R DST RRP12 MACF1 UQCRC1 NIPBL SEC23B | 7.62e-06 | 653 | 178 | 14 | 22586326 | |
| Pubmed | DDX47 GART SMC4 EEF1A1 IGF2BP1 FASN IGF2BP3 RRP12 UQCRC1 GFM1 GOLGA2 SEC23B | 8.29e-06 | 484 | 178 | 12 | 31995728 | |
| Pubmed | MBTPS1 ANKFY1 WDR7 SYNE1 HEATR5A SETDB1 PXDN RRP12 MACF1 DAAM2 RIMBP2 | 8.94e-06 | 407 | 178 | 11 | 12693553 | |
| Pubmed | SYNE1 HMGXB4 RBM26 SMC4 TRRAP EEF1A1P5 INTS5 DST PXDN CSNK1A1 RRP12 INTS15 MACF1 RAI14 CEP131 UQCRC1 PARD3 NIPBL PBXIP1 CBX8 KIF22 CDK7 | 9.12e-06 | 1497 | 178 | 22 | 31527615 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NUP85 PLEKHG4 SNX17 HMGXB4 RBM26 NPAS3 SMC4 TRRAP TRIP12 SH2B1 FASN SIX5 UQCRC1 TOR3A KIF22 SORL1 | 9.54e-06 | 857 | 178 | 16 | 25609649 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.03e-05 | 202 | 178 | 8 | 33005030 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | NUP85 TRIP12 EEF1A1 EEF1A2 IGF2BP1 IGF2BP3 DST CSNK1A1 RRP12 MACF1 PTGES3 ANKS1A | 1.10e-05 | 498 | 178 | 12 | 36634849 |
| Pubmed | MYH11 RBM26 SMC4 TRIP12 EEF1A1 EEF1A2 CSNK1A1 RAI14 NIPBL CDK7 | 1.11e-05 | 340 | 178 | 10 | 24332808 | |
| Pubmed | ACACB ACO2 HMGXB4 TRRAP ZFPM2 CASP12 SETDB1 PALS1 IGF2BP1 IGF2BP3 DST DCP1B RRP12 NCOA1 SIX5 RAI14 CEP131 UQCRC1 NIPBL SEC23B SORL1 | 1.48e-05 | 1429 | 178 | 21 | 35140242 | |
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 30797814 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RANBP10 NUP85 NOB1 TRRAP ADCY9 HDDC3 CCDC88C FASN INTS5 IGF2R DST NEK8 RRP12 LRRC56 LRP4 CEP131 LRBA SOWAHB | 1.64e-05 | 1105 | 178 | 18 | 35748872 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | WDR46 SMC4 IDH2 COPS2 TRRAP TRIP12 LDAH IGF2BP1 FASN IGF2BP3 UQCRC1 LRBA NIPBL SEC23B | 1.76e-05 | 704 | 178 | 14 | 29955894 |
| Pubmed | DDX47 ACO2 GART SIPA1 EEF1A1 IGF2BP1 FASN IGF2BP3 IGF2R CSNK1A1 MACF1 LRBA PTGES3 SEC23B | 1.84e-05 | 707 | 178 | 14 | 19738201 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | A1BG MBTPS1 HMGXB4 UFM1 EEF1A1 ITFG1 EEF1A2 CCDC88C SETDB1 NEK2 FBXL16 GADD45G NRXN2 PIK3CB PEX5 CARD11 GOLGA2 CNTN1 | 2.06e-05 | 1124 | 178 | 18 | 21900206 |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 2.40e-05 | 111 | 178 | 6 | 22558309 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 34643245 | ||
| Pubmed | Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis. | 2.60e-05 | 2 | 178 | 2 | 26830532 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 11002341 | ||
| Pubmed | Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use. | 2.60e-05 | 2 | 178 | 2 | 38167725 | |
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 2.60e-05 | 2 | 178 | 2 | 30782564 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 37358015 | ||
| Pubmed | Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. | 2.60e-05 | 2 | 178 | 2 | 11427698 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 35741005 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 2.60e-05 | 2 | 178 | 2 | 30370994 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 12921532 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 11992722 | ||
| Pubmed | Ankyrin binds to two distinct cytoplasmic domains of Na,K-ATPase alpha subunit. | 2.60e-05 | 2 | 178 | 2 | 8159688 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 26212729 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 21059979 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 17825975 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 22095224 | ||
| Pubmed | KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. | 2.60e-05 | 2 | 178 | 2 | 25499221 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 31014431 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 38220433 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 19636410 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 35869490 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 32806791 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 38331848 | ||
| Pubmed | Structural insight into an ankyrin-sensitive lipid-binding site of erythroid beta-spectrin. | 2.60e-05 | 2 | 178 | 2 | 17520478 | |
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 7945283 | ||
| Pubmed | 2.60e-05 | 2 | 178 | 2 | 32347192 | ||
| Pubmed | RNA-binding IMPs promote cell adhesion and invadopodia formation. | 2.60e-05 | 2 | 178 | 2 | 16541107 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 2.65e-05 | 113 | 178 | 6 | 34474245 | |
| Pubmed | DDX47 MYH11 RBM26 APOB TRIP12 UFM1 EEF1A1 ADH1B EEF1A2 IGF2BP1 FASN IGF2BP3 CEP78 RAI14 CEP131 FLRT3 PARD3 RIOK2 GOLGA2 CBX8 | 2.66e-05 | 1371 | 178 | 20 | 36244648 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GART RBM26 SMC4 IDH2 COPS2 EEF1A1 EEF1A2 IVNS1ABP PALS1 IGF2BP1 FASN IGF2BP3 DST KRT71 RRP12 MACF1 RAI14 PTGES3 | 2.75e-05 | 1149 | 178 | 18 | 35446349 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KRT26 ANK1 SMC4 RNF213 ST3GAL4 CSMD2 TRIP12 EEF1A1 EEF1A2 IVNS1ABP IGF2BP3 DST FBXO43 CEP295 | 2.86e-05 | 736 | 178 | 14 | 29676528 |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 3.52e-05 | 72 | 178 | 5 | 25917818 | |
| Pubmed | 3.59e-05 | 312 | 178 | 9 | 37120454 | ||
| Pubmed | 3.63e-05 | 13 | 178 | 3 | 29285303 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | POF1B ADCY9 EEF1A1 FASN IGF2R DST CSNK1A1 VSIG10L MACF1 RAI14 PARD3 GOLGA2 | 3.79e-05 | 565 | 178 | 12 | 25468996 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX47 GART NOB1 RBM26 SMC4 EEF1A1 YARS2 EEF1A1P5 IGF2BP1 FASN IGF2BP3 CSNK1A1 RRP12 MACF1 RIOK2 PTGES3 NIPBL GOLGA2 SEC23B LRRC15 | 4.14e-05 | 1415 | 178 | 20 | 28515276 |
| Pubmed | 5.04e-05 | 326 | 178 | 9 | 17015433 | ||
| Pubmed | 5.16e-05 | 186 | 178 | 7 | 14744259 | ||
| Pubmed | DDX47 KNTC1 RANBP10 NUP85 NOB1 SMC4 RNF213 GCDH IDH2 COPS2 IGF2BP1 FASN IGF2BP3 DST PXDN RRP12 LRP4 UQCRC1 PTGES3 PBXIP1 | 5.27e-05 | 1440 | 178 | 20 | 30833792 | |
| Pubmed | 5.34e-05 | 187 | 178 | 7 | 26460568 | ||
| Pubmed | 5.58e-05 | 129 | 178 | 6 | 23563607 | ||
| Pubmed | 5.73e-05 | 15 | 178 | 3 | 8812466 | ||
| Pubmed | The nucleoplasmic phase of pre-40S formation prior to nuclear export. | 5.79e-05 | 41 | 178 | 4 | 36321656 | |
| Pubmed | 6.10e-05 | 191 | 178 | 7 | 33762435 | ||
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 7.79e-05 | 3 | 178 | 2 | 17296566 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 11960985 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 2474823 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 7.79e-05 | 3 | 178 | 2 | 23772048 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 7.79e-05 | 3 | 178 | 2 | 24787690 | |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 7.79e-05 | 3 | 178 | 2 | 12399109 | |
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 7.79e-05 | 3 | 178 | 2 | 29476152 | |
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 3011597 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 6756216 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 19559761 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 37806378 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 7840644 | ||
| Pubmed | 7.79e-05 | 3 | 178 | 2 | 8586965 | ||
| Pubmed | Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. | 7.79e-05 | 3 | 178 | 2 | 19252981 | |
| Interaction | THRB interactions | SYNE1 ACO2 PMEL COPS2 TRIP12 EEF1A1 EEF1A2 KIF20A SETDB1 NCOA1 | 5.68e-06 | 186 | 176 | 10 | int:THRB |
| Interaction | ATOH1 interactions | 6.39e-06 | 80 | 176 | 7 | int:ATOH1 | |
| Interaction | YWHAQ interactions | MYH11 PANK3 NLRP7 SPTB SIPA1 TRIP12 EEF1A1 IVNS1ABP CCDC88C MLXIPL FASN IGF2BP3 DST PIK3CB CSNK1A1 SRGAP1 NCOA1 MACF1 RAI14 CEP131 LRBA PARD3 SEC23B ANKS1A CDK7 | 1.44e-05 | 1118 | 176 | 25 | int:YWHAQ |
| Interaction | FER1L6 interactions | 2.23e-05 | 7 | 176 | 3 | int:FER1L6 | |
| GeneFamily | Fibronectin type III domain containing | 4.61e-04 | 160 | 111 | 6 | 555 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.02e-03 | 8 | 111 | 2 | 939 | |
| GeneFamily | Alcohol dehydrogenases | 1.02e-03 | 8 | 111 | 2 | 397 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN | KDM3A KRT26 UFM1 SH2B1 PALS1 FBXL16 IFFO2 LRP4 NCOA1 ARHGAP45 | 1.14e-06 | 200 | 177 | 10 | M8110 |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 9.61e-08 | 195 | 178 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 199 | 178 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.50e-07 | 120 | 178 | 7 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-07 | 179 | 178 | 8 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-07 | 183 | 178 | 8 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 191 | 178 | 8 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 192 | 178 | 8 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.37e-06 | 198 | 178 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 198 | 178 | 8 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 198 | 178 | 8 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.43e-06 | 199 | 178 | 8 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.43e-06 | 199 | 178 | 8 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.48e-06 | 200 | 178 | 8 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-06 | 147 | 178 | 7 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.93e-06 | 154 | 178 | 7 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-06 | 169 | 178 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-06 | 169 | 178 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-06 | 175 | 178 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 177 | 178 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-06 | 177 | 178 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-06 | 181 | 178 | 7 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-06 | 181 | 178 | 7 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-06 | 182 | 178 | 7 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-06 | 183 | 178 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 183 | 178 | 7 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-06 | 185 | 178 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.78e-06 | 185 | 178 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-05 | 186 | 178 | 7 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.05e-05 | 187 | 178 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 187 | 178 | 7 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 188 | 178 | 7 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 188 | 178 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 188 | 178 | 7 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.16e-05 | 190 | 178 | 7 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.16e-05 | 190 | 178 | 7 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 191 | 178 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.20e-05 | 191 | 178 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 191 | 178 | 7 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 193 | 178 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 193 | 178 | 7 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.29e-05 | 193 | 178 | 7 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.29e-05 | 193 | 178 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 193 | 178 | 7 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 194 | 178 | 7 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 194 | 178 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 194 | 178 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 1.33e-05 | 194 | 178 | 7 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 195 | 178 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | 15-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 1.42e-05 | 196 | 178 | 7 | 0e45817625b96d21a8cc4dfbbd465ee6403b6802 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.47e-05 | 197 | 178 | 7 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 198 | 178 | 7 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.52e-05 | 198 | 178 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.52e-05 | 198 | 178 | 7 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.57e-05 | 199 | 178 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.57e-05 | 199 | 178 | 7 | 399e73d45638848e68edda120316ceff04d98680 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.57e-05 | 199 | 178 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-05 | 199 | 178 | 7 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.57e-05 | 199 | 178 | 7 | a0c20b97cb38e493b47a06e9501fc165a78c61b2 | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-05 | 199 | 178 | 7 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 133 | 178 | 6 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-05 | 200 | 178 | 7 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-05 | 200 | 178 | 7 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 1.62e-05 | 200 | 178 | 7 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-05 | 200 | 178 | 7 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.62e-05 | 200 | 178 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 134 | 178 | 6 | 8a3acf32cabc37b49d6488d43cdaae7cec79d119 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 134 | 178 | 6 | 1fa13185a4dfb4563473184c0c4f449011d88631 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 134 | 178 | 6 | 1ab99a22d0d7657f62f8ea7d96bb24e88de54fd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 138 | 178 | 6 | 6b83c434895d82eaf3c222eef27acec76f9c0a77 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.92e-05 | 148 | 178 | 6 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.03e-05 | 149 | 178 | 6 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 151 | 178 | 6 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 3.92e-05 | 156 | 178 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.84e-05 | 162 | 178 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-05 | 163 | 178 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-05 | 163 | 178 | 6 | 6c4d4c55fc8a731acca13c1ba7287f238a9d81e0 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.18e-05 | 164 | 178 | 6 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 164 | 178 | 6 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-05 | 165 | 178 | 6 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 167 | 178 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.73e-05 | 167 | 178 | 6 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 178 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 178 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 169 | 178 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 169 | 178 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 170 | 178 | 6 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.53e-05 | 171 | 178 | 6 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.53e-05 | 171 | 178 | 6 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 172 | 178 | 6 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-05 | 174 | 178 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.19e-05 | 174 | 178 | 6 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-05 | 174 | 178 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-05 | 174 | 178 | 6 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.42e-05 | 175 | 178 | 6 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.66e-05 | 176 | 178 | 6 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 178 | 178 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 179 | 178 | 6 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 2.09e-07 | 3 | 176 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | melanoma | 2.63e-06 | 248 | 176 | 10 | C0025202 | |
| Disease | C-reactive protein measurement | LRRC3C SNX17 APOB CCDC168 LRRC43 TRIP12 NT5DC1 ADCY9 ZFPM2 ADH1B MLXIPL ZNF469 IGF2BP1 IGF2BP3 PXDN GADD45G MACF1 SYT4 CREB3L3 EPHA7 ANKS1A | 1.14e-05 | 1206 | 176 | 21 | EFO_0004458 |
| Disease | Liver carcinoma | MBTPS1 ACO2 KIF20A MLXIPL HHIP NEK2 IGF2BP1 FASN IGF2BP3 IGF2R BCO2 NEIL3 CEP131 | 1.22e-05 | 507 | 176 | 13 | C2239176 |
| Disease | phospholipids in medium VLDL measurement | 1.48e-05 | 52 | 176 | 5 | EFO_0022154 | |
| Disease | cholesterol in small VLDL measurement | 1.62e-05 | 53 | 176 | 5 | EFO_0022228 | |
| Disease | alcohol consumption measurement | CACNA1D ACACB ACO2 SNX17 NPAS3 ALPK1 GRM3 SH2B1 FAM135B ADH1A ADH1B MLXIPL IGF2BP1 INTS5 CNTNAP5 SYT4 PARD3 SEC23B CBX8 SORL1 ANKS1A | 1.76e-05 | 1242 | 176 | 21 | EFO_0007878 |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.43e-05 | 10 | 176 | 3 | OBA_2045163 | |
| Disease | gout | 2.46e-05 | 196 | 176 | 8 | EFO_0004274 | |
| Disease | triacylglycerol 52:3 measurement | 9.00e-05 | 15 | 176 | 3 | EFO_0010415 | |
| Disease | tumor necrosis factor receptor superfamily member 21 measurement | 1.06e-04 | 3 | 176 | 2 | EFO_0020810 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.13e-04 | 126 | 176 | 6 | EFO_0004611, EFO_0010351 | |
| Disease | alcohol dependence | 1.20e-04 | 183 | 176 | 7 | MONDO_0007079 | |
| Disease | free cholesterol in medium VLDL measurement | 1.79e-04 | 47 | 176 | 4 | EFO_0022269 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.97e-04 | 264 | 176 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | cholesterol in medium LDL measurement | 2.10e-04 | 49 | 176 | 4 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 2.10e-04 | 49 | 176 | 4 | EFO_0022227 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 2.11e-04 | 4 | 176 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | total lipids in medium LDL | 2.65e-04 | 52 | 176 | 4 | EFO_0022180 | |
| Disease | fat intake measurement | 2.96e-04 | 22 | 176 | 3 | EFO_0010809 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 3.50e-04 | 5 | 176 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 3.50e-04 | 5 | 176 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 3.50e-04 | 5 | 176 | 2 | C0221409 | |
| Disease | muscular disease (implicated_via_orthology) | 3.50e-04 | 5 | 176 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.90e-04 | 222 | 176 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | response to gemcitabine | 4.36e-04 | 25 | 176 | 3 | GO_0036272 | |
| Disease | phospholipids:total lipids ratio | 4.46e-04 | 227 | 176 | 7 | EFO_0020946 | |
| Disease | phospholipids in small VLDL measurement | 4.60e-04 | 60 | 176 | 4 | EFO_0022146 | |
| Disease | galectin-7 measurement | 5.22e-04 | 6 | 176 | 2 | EFO_0022034 | |
| Disease | Enterovirus Infections | 5.22e-04 | 6 | 176 | 2 | C0014378 | |
| Disease | renal system measurement, uric acid measurement | 5.22e-04 | 6 | 176 | 2 | EFO_0004742, EFO_0004761 | |
| Disease | macrophage colony-stimulating factor 1 receptor measurement | 5.22e-04 | 6 | 176 | 2 | EFO_0020547 | |
| Disease | reticulocyte count | ANK1 SPTB SNX17 GCDH ST3GAL4 TAC4 SIPA1 TFR2 ADH1B MLXIPL ZNF469 NEK8 RAI14 HBM ARHGAP45 PTGES3 | 5.52e-04 | 1045 | 176 | 16 | EFO_0007986 |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 6.20e-04 | 114 | 176 | 5 | EFO_0004574, EFO_0004611 | |
| Disease | apolipoprotein B measurement | ANK1 ACACB SNX17 APOB ST3GAL4 TAC4 LDAH TFR2 ADH1B MLXIPL IGF2R ANXA9 | 6.66e-04 | 663 | 176 | 12 | EFO_0004615 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 6.67e-04 | 243 | 176 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | Abnormality of refraction | CACNA1D GRIA4 ST3GAL4 GRM3 NT5DC1 HHIP CNTNAP5 GALNT8 WNT10A RIMBP2 PARD3 SEC23B | 7.58e-04 | 673 | 176 | 12 | HP_0000539 |
| Disease | coffee consumption measurement | 8.08e-04 | 182 | 176 | 6 | EFO_0006781 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 8.71e-04 | 71 | 176 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | Hereditary spherocytosis | 9.67e-04 | 8 | 176 | 2 | C0037889 | |
| Disease | Familial hypercholesterolemia | 9.67e-04 | 8 | 176 | 2 | cv:C0020445 | |
| Disease | very low density lipoprotein cholesterol measurement | 9.90e-04 | 260 | 176 | 7 | EFO_0008317 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.09e-03 | 34 | 176 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | Antihypertensive use measurement | 1.11e-03 | 265 | 176 | 7 | EFO_0009927 | |
| Disease | cancer (implicated_via_orthology) | 1.18e-03 | 268 | 176 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | scavenger receptor cysteine-rich type 1 protein m130 measurement | 1.24e-03 | 9 | 176 | 2 | EFO_0020717 | |
| Disease | Gout | 1.24e-03 | 9 | 176 | 2 | C0018099 | |
| Disease | grip strength measurement | 1.25e-03 | 350 | 176 | 8 | EFO_0006941 | |
| Disease | fatty acid measurement | 1.28e-03 | 436 | 176 | 9 | EFO_0005110 | |
| Disease | metabolic syndrome | 1.31e-03 | 200 | 176 | 6 | EFO_0000195 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.34e-03 | 274 | 176 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.40e-03 | 37 | 176 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.40e-03 | 37 | 176 | 3 | EFO_0022252 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 1.54e-03 | 10 | 176 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | diet measurement | ACO2 RBM26 NPAS3 APOB ALPK1 COPS2 ZFPM2 MLXIPL ZNF469 DST GADD45G SYT4 NIPBL EPHA7 SORL1 | 1.62e-03 | 1049 | 176 | 15 | EFO_0008111 |
| Disease | testosterone measurement | CACNA1D SPNS2 CYP27B1 SH2B1 ADCY9 ZFPM2 ADH1B RGS14 MLXIPL FASN MGAT5 NCOA1 MACF1 DAAM2 RIMBP2 ANXA9 CBX8 | 1.69e-03 | 1275 | 176 | 17 | EFO_0004908 |
| Disease | Autism Spectrum Disorders | 1.70e-03 | 85 | 176 | 4 | C1510586 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.88e-03 | 11 | 176 | 2 | OBA_2045170 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.89e-03 | 291 | 176 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.89e-03 | 215 | 176 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.13e-03 | 220 | 176 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | triglycerides in large LDL measurement | 2.16e-03 | 43 | 176 | 3 | EFO_0022319 | |
| Disease | risk-taking behaviour | CACNA1D SH2B1 ADH1B CASP12 TNNI3K CNTNAP5 GADD45G RRP12 LRP4 CNTN2 CBX8 SORL1 | 2.21e-03 | 764 | 176 | 12 | EFO_0008579 |
| Disease | serine protease 27 measurement | 2.24e-03 | 12 | 176 | 2 | EFO_0008280 | |
| Disease | alcohol consumption measurement, alcohol drinking | 2.24e-03 | 12 | 176 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.29e-03 | 153 | 176 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.38e-03 | 225 | 176 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.38e-03 | 225 | 176 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | cognitive function measurement | KNTC1 CACNA1D ANKFY1 GRIA4 GRM3 SH2B1 FAM135B ZFPM2 TGFBI TNNI3K IGF2BP1 CNTNAP5 GADD45G SRGAP1 SYT4 RIMBP2 SOWAHB EPHA7 | 2.39e-03 | 1434 | 176 | 18 | EFO_0008354 |
| Disease | visceral adipose tissue measurement | 2.50e-03 | 481 | 176 | 9 | EFO_0004765 | |
| Disease | HbA1c measurement | ANK1 ACACB SPTB CYP27B1 TAC4 ADCY9 TFR2 MLXIPL IGF2BP3 MACF1 ARHGAP45 | 2.53e-03 | 675 | 176 | 11 | EFO_0004541 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.60e-03 | 229 | 176 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | mood disorder | 2.64e-03 | 13 | 176 | 2 | EFO_0004247 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.64e-03 | 13 | 176 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | IGF-1 measurement | 2.75e-03 | 488 | 176 | 9 | EFO_0004627 | |
| Disease | total lipids in small LDL | 2.79e-03 | 47 | 176 | 3 | EFO_0022168 | |
| Disease | hemolysis | 2.79e-03 | 47 | 176 | 3 | EFO_0009473 | |
| Disease | free cholesterol in small VLDL measurement | 2.79e-03 | 47 | 176 | 3 | EFO_0022272 | |
| Disease | smoking status measurement, carotid artery intima media thickness | 2.96e-03 | 48 | 176 | 3 | EFO_0006527, EFO_0007117 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.96e-03 | 99 | 176 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | phospholipids in medium LDL measurement | 3.14e-03 | 49 | 176 | 3 | EFO_0022183 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 3.14e-03 | 49 | 176 | 3 | EFO_0022256 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.20e-03 | 239 | 176 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CACNA1D KDM3A NPAS3 GRIA4 FAM135B TNNI3K CNTNAP5 MGAT5 NRXN2 SYT4 CBX8 SORL1 | 3.24e-03 | 801 | 176 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.26e-03 | 166 | 176 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 3.30e-03 | 102 | 176 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.33e-03 | 50 | 176 | 3 | EFO_0022247 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.42e-03 | 103 | 176 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 3.53e-03 | 15 | 176 | 2 | OBA_2045165 | |
| Disease | total lipids in LDL measurement | 3.72e-03 | 52 | 176 | 3 | EFO_0022308 | |
| Disease | JT interval | 3.84e-03 | 248 | 176 | 6 | EFO_0007885 | |
| Disease | Hyperlipoproteinemia Type IIa | 4.02e-03 | 16 | 176 | 2 | C0745103 | |
| Disease | vision disorder | 4.02e-03 | 16 | 176 | 2 | MONDO_0021084 | |
| Disease | central nervous system disease (implicated_via_orthology) | 4.02e-03 | 16 | 176 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | remnant cholesterol measurement | 4.05e-03 | 108 | 176 | 4 | EFO_0010815 | |
| Disease | total lipids in medium VLDL | 4.14e-03 | 54 | 176 | 3 | EFO_0022153 | |
| Disease | parathyroid hormone measurement | 4.36e-03 | 55 | 176 | 3 | EFO_0004752 | |
| Disease | ecosanoids measurement | 4.36e-03 | 55 | 176 | 3 | EFO_0020044 | |
| Disease | Alzheimer disease, psychotic symptoms | 4.54e-03 | 17 | 176 | 2 | EFO_0005940, MONDO_0004975 | |
| Disease | cholesteryl ester measurement | 4.56e-03 | 257 | 176 | 6 | EFO_0010351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRGHLDNISNNLLIG | 606 | Q99798 | |
| AIDLFRQAGLGNHLS | 391 | Q15582 | |
| KLHRALQAQRGAGLA | 61 | Q7Z4H4 | |
| GRLIDHLENTKGFNL | 151 | Q9H0S4 | |
| NQVLLKFHRDAATGG | 2266 | Q7Z408 | |
| NQLLELDHQKRGGAR | 406 | P61201 | |
| KDLLLSGSSGDLQQH | 181 | Q68CJ9 | |
| INEGFDLLHSGKSIR | 356 | P07327 | |
| INEGFDLLHSGKSIR | 356 | P00325 | |
| RSGNLDKALDHLRNG | 21 | P16157 | |
| SKGFLLSLGDHNFLR | 16 | Q14832 | |
| LKRLVLDGNLLNNHG | 201 | Q9NZU0 | |
| LDIGAKFQLENRKGH | 611 | Q9NU02 | |
| KLLLNGFDDVHFLGS | 716 | Q92625 | |
| FHAFLDLLKDAGLGQ | 531 | Q5JTW2 | |
| LAHFLRGTKDGIQNA | 111 | Q96NB1 | |
| LQNLRKAGEGLDQVH | 386 | Q9BYV7 | |
| KASADTHGRLLQGNI | 236 | Q6UXS9 | |
| SFECRLDKLILHGQG | 436 | Q96QP1 | |
| LQQRLRGTQDGSKHF | 331 | Q969G9 | |
| LLDHGADVNSRNKSG | 171 | Q9P0K7 | |
| LSEQLGREYGKNLAH | 521 | Q6VN20 | |
| AAVHGARFKGQDLKL | 941 | Q5T8P6 | |
| LQLHLTEKNLYGRLG | 301 | Q96N11 | |
| FLGNEHSLLSGNEKV | 71 | Q7Z3Y9 | |
| AAFQGLEGTLRHLDL | 121 | A6NJW4 | |
| AIKHQFLLTGDTQGR | 76 | P04217 | |
| EIDAHRLNDGGLLLS | 846 | O00763 | |
| SLLHKGIQRGDLFAA | 291 | Q9P2R3 | |
| ELFCKGGLSRLHELQ | 51 | O15528 | |
| NAGAGEDNLEFRLHL | 286 | Q86T65 | |
| AGAFLRHAALQDIGK | 11 | Q9ULX3 | |
| LKLANNGTVLRASHG | 76 | Q5TFE4 | |
| KLQGRLQLFGQDFSH | 751 | Q92619 | |
| GNIIKNEALFDSGLH | 191 | Q8TAT5 | |
| KLGDFGLARILNHDT | 156 | P51955 | |
| QGHGKLDLLRAYQIL | 461 | Q14703 | |
| VKNHGILSGRDLQFL | 491 | Q09328 | |
| SADHKLLDGNLLDGQ | 226 | Q9Y6Y0 | |
| INRQHKLEGALLALG | 6366 | Q03001 | |
| ILAHNNFVGRLIGKE | 281 | Q9NZI8 | |
| GLQGTNRQLEEALKH | 156 | Q8N4P3 | |
| AHQRNDLGQLDGKVF | 881 | Q8WW38 | |
| GELDRVNFLHHQLKG | 1256 | Q9P219 | |
| FILGLLDAGKAHLQR | 186 | P06126 | |
| NLGFKDISLERFIHG | 241 | P48058 | |
| GLLHEFRKGNASKEQ | 66 | Q8IZT8 | |
| LFNESHGIFLGLQRI | 71 | Q9BW27 | |
| ILLFNAHDRDSGKNG | 366 | Q9Y5G4 | |
| AHGRQKILDLLNEGS | 586 | Q14807 | |
| AGHFTQDKALRQEGL | 21 | P50542 | |
| LLLGKHQLNELGSES | 1231 | Q6KC79 | |
| HSNGARNLDLKGELY | 1026 | Q9P2S2 | |
| SNRFNKLGLDHLSLG | 521 | Q86SG6 | |
| RQHKLEGALLALGQF | 2341 | O94854 | |
| EGALLALGQFQHALE | 2346 | O94854 | |
| LNLQGGKFDHADRTF | 2326 | P50851 | |
| GKFLLVGERSGNLHL | 96 | P50748 | |
| ALLGHNVGDLQKARS | 556 | Q96KJ4 | |
| NRFHGDAQVALLGLA | 251 | O76027 | |
| EQGALLLGHELQSFL | 231 | Q9UGU5 | |
| NGALDAFLRKHDGQF | 716 | Q15375 | |
| HLRKELEGLAGQLQA | 471 | Q08379 | |
| HSLLELERLLGKFGQ | 71 | Q86X67 | |
| GKNILRNALVSHLDG | 391 | P31930 | |
| LEHLQRIGGSKQDFE | 276 | Q8WVV4 | |
| ILAHNNFVGRLIGKE | 281 | O00425 | |
| KDLTLFGRRGNLHFI | 71 | Q9H999 | |
| CRELGLSFQKGDILH | 366 | Q8N3R9 | |
| KRLQENSGHEFLEQG | 456 | Q4G163 | |
| LNEHKERLITLGFGN | 226 | Q7RTM1 | |
| GKGRDISLAALQRHD | 11 | Q8IZD4 | |
| IAGSLEGHLRFLKNI | 3661 | P04114 | |
| HRGKLDGNQDLIRFA | 381 | P48735 | |
| LDKLGLSQAVFIGHD | 321 | P34913 | |
| TDHRFIEEQLLLGNG | 731 | Q86XA9 | |
| LQFNKHGVLRVEGFL | 576 | Q9Y4C1 | |
| KHRAAFLEAKGQGAL | 286 | Q9HC52 | |
| AHLRLLKLAESGNLN | 306 | Q8NA47 | |
| GLHACLQLGRLKDQD | 346 | Q92947 | |
| GLLDAFGHKSNISLV | 76 | P50613 | |
| GAGKALHELLLSAQR | 21 | O95257 | |
| LAANRHFLGEIGSLD | 361 | Q9NY28 | |
| GISKNGQTREHALLA | 126 | Q05639 | |
| GISKNGQTREHALLA | 126 | P68104 | |
| GELLIRNAQLKHAGR | 566 | Q12860 | |
| SAHALVGLLNDLFGR | 411 | O60503 | |
| DLTILNAQLRHGGKY | 571 | Q02246 | |
| GSNIHLLKGLNVRFR | 51 | Q5TF58 | |
| GISKNGQTREHALLA | 126 | Q5VTE0 | |
| GRKHTLLANNGFAIS | 136 | Q9NRM0 | |
| LLDGATFHQTLLKEG | 166 | Q6UWL6 | |
| LGEAGLHFDELNKLR | 6 | Q8IY31 | |
| GKDLDFHKLENQGSR | 1841 | Q8NDH2 | |
| HGLDGNSADLRLVKT | 1146 | Q49AJ0 | |
| LIAGHEAQFGAELLL | 16 | Q6B0K9 | |
| DNLEFFLAGIGRLHL | 791 | P49327 | |
| LLLHRQRDLGDSKSG | 1081 | Q9C0D2 | |
| GHKLSGLRFVLQDGA | 601 | Q96RP9 | |
| LRAGFTLQEALGALH | 581 | Q92681 | |
| QLAGALDFLHSRGLV | 146 | P0C264 | |
| RGAGAARLEHLLQAK | 286 | Q9UPN4 | |
| NRAGRLLDILHTKGQ | 71 | Q9BXL7 | |
| DDVFKRNGALLGNHV | 1676 | Q01668 | |
| GRLALHLNLGDSKAR | 236 | Q8WYK1 | |
| HLFRGLSLNGDLLAQ | 291 | Q8N309 | |
| KGNRSKENHADLGIF | 606 | Q8TEW0 | |
| QDFGLKHLLALGSLR | 411 | Q8N461 | |
| LKFLHQDIDSGQGIR | 1051 | P11717 | |
| DLGNLTHLFLHGNRI | 176 | Q9BZR6 | |
| SLHLDLEKRDLNGNF | 91 | Q9H2B2 | |
| FRQHAGKIDLLGGSA | 61 | O15034 | |
| NKKNGNAIFRHLLGD | 416 | A5PLK6 | |
| QGKAKHLRLSLNEEG | 571 | Q9NRF2 | |
| LNFRGSILSHKVGNL | 1796 | Q92673 | |
| LQAKHDLLQRTLGEG | 456 | Q7Z6B7 | |
| GDHSALESQIRQLGK | 8326 | Q8NF91 | |
| DGAFDHLVGLTKLNL | 166 | Q8TF66 | |
| DQLKLNGSHLGSLRD | 96 | Q8IYG6 | |
| HSLGSEQFRGLRKLL | 146 | Q86VH5 | |
| LRGQRAHLFGNLEKL | 771 | Q58EX7 | |
| SLRLGQLKGNHFDIV | 381 | Q9H0K6 | |
| AHSGAQGLLAAQKAR | 31 | Q9Y2Z4 | |
| GLLHNNDRLSDGDSK | 611 | Q15788 | |
| IGRHCNKLFLIDFGL | 146 | P48729 | |
| DRKGQLVLFHADGQT | 246 | Q9UK23 | |
| EALLQAGHAGRLSRF | 96 | Q8N196 | |
| GHRLRNSSLGDAINK | 126 | Q11206 | |
| FLLAKALNGEQAAGH | 506 | Q96FS4 | |
| LLDIQQHFGVKDRGA | 126 | Q8IVW8 | |
| IQVGHFLFGLANEKR | 516 | Q8WX94 | |
| EGIRHSHLDLLNKGQ | 376 | Q8IXF0 | |
| DALVHFGKRGLNVAA | 116 | Q9H902 | |
| LLVEGALHRGNTELF | 691 | Q6P9B9 | |
| FDFKGQLRTGDIILH | 446 | P42338 | |
| QLRALDGGNKHFLRN | 221 | P40967 | |
| RRFNIKLGFDTLHGL | 661 | Q9NP71 | |
| HGDLRALQDLVSGAK | 641 | A6NEL2 | |
| AELHRKHLGGQLLFG | 346 | Q96QV1 | |
| VKLHNELQSGSLRLG | 56 | Q5JTH9 | |
| EHGGSQARFLLSKVN | 711 | Q15437 | |
| DAKLEGNLGRYLNHS | 1211 | Q15047 | |
| EKIHRQLAQLGGLDA | 31 | P54922 | |
| FRLQGLQAVLAIDGH | 26 | Q8N6V4 | |
| KTHRQGASFLGILDI | 446 | P35749 | |
| LGLHEQLRKEYGANV | 41 | Q15036 | |
| GFLSKHSSDGLRQLL | 4811 | Q63HN8 | |
| ELGHRLAQKLQGLEN | 431 | Q96AQ6 | |
| LGGSDNFKHLNEIDL | 41 | Q15185 | |
| GERLKEAGNINTSLH | 421 | O95235 | |
| GAILHLNGRLQKAEA | 786 | Q8N394 | |
| FLAGDHRANEQLGLT | 971 | Q92626 | |
| LQKADLNHLGALGSD | 776 | Q9HBJ7 | |
| HSGAFLLAQREKGLL | 156 | Q96FA7 | |
| FKDVGNLLRSHGIDL | 206 | Q9NTJ3 | |
| SGAHDQRGLLRKEDL | 511 | O43566 | |
| KQLASRAQGLLSAGH | 1641 | P11277 | |
| TSGLDHQLKIFDLRG | 376 | O15213 | |
| QALGLEVFHAGTALK | 361 | P22102 | |
| EGQQFALKLHRLGRT | 116 | Q9BVS4 | |
| QTAGNVFLKHGSELR | 61 | P61960 | |
| QFCGLLLARAKDGHQ | 751 | Q96JG9 | |
| LLGQNHDIFDLRGKS | 121 | Q9GZX5 | |
| GKVFSQNAGLLEHLR | 316 | Q16670 | |
| CGKGFNQTLDLIRHL | 191 | Q5MCW4 | |
| SQDGRKLHIGNFSLD | 631 | Q86VR7 | |
| RLQLDALQRGKGLSH | 176 | Q9GZT5 | |
| NHRGLDGLKRNVTLQ | 86 | Q9UJV3 | |
| NGFGHSRLVKENLID | 316 | Q9H497 | |
| NVLGLGRSANFLDHL | 501 | Q8TB96 | |
| RRHSKAILQAGGLAD | 551 | Q14669 | |
| GHIRLVQFLLDNGAD | 351 | Q59H18 | |
| QLEHTFQGLLGKRSL | 86 | Q86UU9 | |
| HKLLIQGDSSGRLNI | 341 | Q9Y4E6 | |
| LRHIGNLNEFSGDLK | 651 | Q9UP52 | |
| RLHNLAQFEGGESKV | 3821 | Q9Y4A5 | |
| QLAAGRHGDDLKNTK | 331 | Q3SY84 | |
| GLNGQIEHKLAFLRT | 111 | Q9H6V9 | |
| NLDGSHRKAVISQGL | 626 | O75096 |